Most people with type 2 diabetes find out through a blood test, not through dramatic symptoms. The condition often develops gradually over years, and many people have elevated blood sugar long before they feel anything unusual. In a study of newly diagnosed patients, roughly nine out of ten did present with at least one symptom of high blood sugar, but those symptoms had typically been present for fewer than three months before diagnosis, suggesting the disease itself had been silently progressing much longer.1PubMed. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight That gap between what you feel and what your blood reveals is exactly why knowing when and how to get tested matters so much.
Symptoms That Suggest High Blood Sugar
The classic signs of type 2 diabetes are driven by excess glucose in the bloodstream. When your kidneys cannot reabsorb all that sugar, they pull extra water along with it, which leads to frequent urination. That fluid loss makes you thirsty, so you drink more. Meanwhile, your cells are not getting the energy they need from glucose, so you feel tired and may lose weight without trying. Blurry vision can happen when fluid shifts affect the shape of the lens in your eye. Slow-healing cuts, recurring skin infections, and tingling or numbness in the hands or feet are also common complaints.
The tricky part is that none of these symptoms is specific to diabetes. Fatigue and thirst have dozens of explanations. Tingling in the feet could be a pinched nerve. And many people with mildly elevated blood sugar feel perfectly fine. Skin changes, including darkened patches on the neck or armpits (a condition sometimes called acanthosis nigricans) and recurring fungal infections, can sometimes be the first visible clue that blood sugar has been running high.2PubMed. Cutaneous manifestations of diabetes. Signs of poor glycemic control or new-onset disease If you notice any cluster of these signs, a simple blood test can settle the question quickly.
The Three Main Diagnostic Tests
Doctors rely on three blood tests to diagnose type 2 diabetes, and each one measures blood sugar in a different way. Understanding their strengths and weaknesses helps you make sense of your results.
HbA1c (Glycated Hemoglobin)
This test reflects your average blood sugar over the previous two to three months. A result of 6.5% or higher is the standard diagnostic threshold for diabetes, and a result between 5.7% and 6.4% falls into the prediabetes range. The convenience is obvious: you do not need to fast, and you can have your blood drawn at any time of day. But HbA1c has a significant blind spot. A meta-analysis of 17 studies found that at the 6.5% cutoff, the test catches only about half of people who actually have diabetes, even though it is very good at ruling in those it flags positive (specificity around 97%).3PLoS ONE. Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis In other words, a normal HbA1c does not guarantee your blood sugar is fine.
Several conditions can throw off HbA1c results entirely. Anything that alters the lifespan of your red blood cells, including anemia, sickle cell disease, significant blood loss, pregnancy, or chronic kidney disease, can make the number unreliable.4PubMed Central. Pitfalls in hemoglobin A1c measurement: when results may be misleading Race and ethnicity also matter. Research has shown that at HbA1c levels below 6.5%, African Americans may already have higher rates of microvascular complications like kidney disease and retinopathy, suggesting the standard cutoff may miss diabetes-related damage in some populations.5PubMed Central. Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications
Fasting Plasma Glucose
This test requires an overnight fast of at least eight hours. A result of 126 mg/dL (7.0 mmol/L) or higher on two separate occasions confirms diabetes, while 100 to 125 mg/dL is considered prediabetes. It is cheaper and more widely available than the other tests. The downside is that a single result is not enough for a diagnosis, so you have to come back for a repeat test. The test also has relatively low specificity for catching early blood sugar problems, and fasting glucose tends to rise later in the progression of the disease, which means it can miss people in earlier stages.6Clinical Diabetes. Detection and Intervention: Use of Continuous Glucose Monitoring in the Early Stages of Type 2 Diabetes
Oral Glucose Tolerance Test
The oral glucose tolerance test (OGTT) is the most sensitive of the three. You fast overnight, drink a sugary solution, and then have your blood sugar measured two hours later. A two-hour reading of 200 mg/dL or above means diabetes, while 140 to 199 mg/dL means prediabetes. This test picks up problems with how your body handles sugar after meals, which is often where things go wrong first. Research has shown that about a third of men and over 40% of women who meet the diabetes threshold on the OGTT are classified as normal by the fasting glucose test alone.7Archives of Internal Medicine. Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria Head-to-head comparisons also indicate that the two-hour glucose reading is better than fasting glucose at detecting early retinopathy.8BMJ. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes
The catch is that the OGTT is cumbersome. You have to fast, sit in a clinic for two hours, and the results can vary from day to day depending on stress, illness, or physical activity.6Clinical Diabetes. Detection and Intervention: Use of Continuous Glucose Monitoring in the Early Stages of Type 2 Diabetes This is why it is not routinely used as a first-line screening tool in most primary care settings, even though it catches more cases.
Why Different Tests Give Different Answers
One of the most confusing things for patients is getting a “normal” result on one test and an “abnormal” result on another. This happens because each test captures a different snapshot of your metabolism. HbA1c averages your glucose over months, fasting glucose measures it at one point in time after an overnight fast, and the OGTT stresses your system with a sugar load and watches how you recover. Two people with identical HbA1c readings can have very different patterns of daily blood sugar spikes. Someone whose blood sugar surges after meals but returns to normal overnight might have a fine fasting glucose while their post-meal readings are clearly abnormal.
This is why clinicians sometimes order more than one test, especially when results are borderline or when there is a strong clinical suspicion despite a normal initial screen. If you have risk factors and one test comes back normal, it does not necessarily close the case.
The Prediabetes Window
Prediabetes is the zone between normal blood sugar and full diabetes. It means your blood sugar is elevated but not yet high enough to meet the diabetes threshold. Definitions vary slightly between different medical organizations, but the general markers are a fasting glucose of 100 to 125 mg/dL, a two-hour OGTT reading of 140 to 199 mg/dL, or an HbA1c of 5.7% to 6.4%.9PubMed Central. Prediabetes diagnosis and treatment: A review
Prediabetes is not a death sentence for your metabolism. Somewhere between 5% and 10% of people with prediabetes progress to full diabetes each year, and a meta-analysis found that the incidence rate for those with elevated HbA1c was roughly 36 per 1,000 person-years, similar to rates seen with other prediabetes definitions.10PubMed. Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis That means many people with prediabetes will not develop diabetes, especially if they make lifestyle changes. Weight loss of even a modest amount, regular physical activity, and dietary adjustments can significantly reduce the progression rate. This is the window where intervention pays off the most.
Who Should Get Screened
The U.S. Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who are overweight or obese, a threshold that was lowered from age 40 in the 2021 update.11JAMA. New USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes: An Opportunity to Create National Momentum But weight is not the only reason to get tested. A family history of diabetes, a personal history of gestational diabetes, polycystic ovary syndrome, or membership in certain higher-risk ethnic groups (including South Asian, East Asian, Black, Hispanic, and Native American populations) all lower the bar for when screening makes sense.
Simple risk-score questionnaires exist that can help you decide whether to pursue formal testing. The Finnish Diabetes Risk Score (FINDRISC), for example, uses questions about age, body mass index, waist circumference, physical activity, diet, and family history to estimate your risk. Studies have found that these questionnaires have moderate accuracy for identifying undiagnosed diabetes.12PubMed Central. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population At a score of 9 or above on the original FINDRISC, sensitivity for detecting drug-treated diabetes was around 78% to 81%.13Diabetes Care. The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk These tools are useful for initial triage, not for replacing a blood test, but they can nudge you to book that appointment.
The Body Weight Question and Ethnic Differences
There is a widespread assumption that type 2 diabetes is a disease of severely overweight people. While higher body weight is indeed a major risk factor, the threshold at which weight starts driving diabetes risk varies dramatically by ethnicity. Research has shown that for the same diabetes incidence rate seen in white individuals at a BMI of 30 (the clinical cutoff for obesity), the equivalent BMI was 24 in South Asian populations, 25 in Chinese populations, and 26 in Black populations.14Diabetes Care. Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk A BMI of 24 is technically in the “normal weight” range by standard classification.
East Asian populations in particular develop type 2 diabetes at lower average BMIs than people of European descent. At any given BMI, East Asian individuals tend to carry more body fat overall and proportionally more of it around the organs in the abdomen, which is the type of fat most strongly linked to insulin resistance.15PubMed Central. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States This means that waiting until someone hits a BMI of 30 before considering diabetes screening misses a large number of people in these populations. If you are of South Asian, East Asian, or other high-risk descent, discuss screening with your doctor even if your weight seems “normal.”
Damage That May Already Be There at Diagnosis
Because type 2 diabetes can simmer undetected for years, many people already have complications by the time they are diagnosed. Studies of newly diagnosed patients have found that more than half already had signs of neuropathy (nerve damage) and nearly 60% had hypertension.16International Journal of Diabetes Mellitus. Chronic complications of diabetes mellitus in newly diagnosed patients Retinopathy (damage to blood vessels in the eye) and nephropathy (early kidney disease) were also found in a notable percentage of people receiving their first diabetes diagnosis.17PubMed Central. Chronic complications in newly diagnosed patients with Type 2 diabetes mellitus in India
This is not meant to scare you, but it does explain why doctors push for early and regular screening, especially in higher-risk groups. The complications of diabetes are driven by how long blood sugar stays elevated, not by how long you have known about the diagnosis. Every year of undetected high blood sugar gives those complications a head start.
Is It Definitely Type 2
If you are diagnosed with diabetes, your doctor still needs to determine the type. Type 2 accounts for roughly 90% of all diabetes cases and typically develops in adulthood, but the boundaries are not always clear. Type 1 diabetes, once thought to occur only in children, can be diagnosed at any age. A form called latent autoimmune diabetes in adults (LADA) looks like type 2 at first but progresses more quickly toward needing insulin because the immune system is attacking the insulin-producing beta cells.
When the type is unclear, measuring diabetes-specific autoantibodies in the blood is the most reliable way to distinguish type 1 from type 2.18The BMJ. Distinguishing between type 1 and type 2 diabetes A C-peptide blood test can also help, since C-peptide is a byproduct of insulin production: low levels suggest the body is making little insulin (pointing toward type 1), while normal or elevated levels suggest insulin resistance with adequate production (pointing toward type 2). A meta-analysis found that fasting or random C-peptide levels at or below 0.20 nmol/L were indicative of type 1, while levels at or above 0.30 nmol/L pointed to type 2.19Endocrine Practice. Predictive Ability of Plasma C-Peptide Levels in Discriminating Type 1 from Type 2 Diabetes: A Systematic Review and Meta-Analysis Getting the type right matters because the treatment strategies differ substantially.
What Is Happening Inside Your Body
In type 2 diabetes, two things go wrong, usually in tandem. First, your body’s cells become resistant to insulin, the hormone that tells them to absorb glucose from the blood. Second, the insulin-producing beta cells in the pancreas start to wear out. Early on, the beta cells compensate for resistance by pumping out more insulin, and blood sugar stays relatively normal. Over time, the beta cells become exhausted and their mass actually decreases, which is when blood sugar begins rising persistently.20European Journal of Inflammation. Pancreatic Beta-cell Dysfunction in Type 2 Diabetes Both of these processes feed each other: insulin resistance forces the beta cells to work harder, and declining beta cell function worsens the body’s ability to manage blood sugar.21PubMed Central. Beta cell dysfunction and insulin resistance
This explains why early intervention is so valuable. At the stage when insulin resistance is high but the beta cells are still functioning, lifestyle changes and certain medications can reduce the workload on those cells and potentially preserve their function for years longer.
Medications That Can Push Blood Sugar Up
Not every case of elevated blood sugar is “classic” type 2 diabetes driven by weight and genetics. Several commonly prescribed medications can raise blood sugar or unmask a tendency toward diabetes that was previously borderline. Corticosteroids (like prednisone), used for conditions ranging from asthma to autoimmune disease, are among the most well-known culprits. Certain psychiatric medications, some blood pressure drugs (particularly thiazide diuretics), and immunosuppressants can also contribute to hyperglycemia.22PubMed Central. Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies If you are on any of these classes of medication and your blood sugar starts creeping up, it is worth discussing with your prescriber whether the medication could be a factor, rather than simply assuming you have developed type 2 diabetes on your own.
Continuous Glucose Monitors as a Newer Tool
Continuous glucose monitors (CGMs), small sensors worn on the skin that check blood sugar every few minutes, are primarily used by people who already have diabetes to manage their treatment. But there is growing interest in their potential as a diagnostic tool for catching blood sugar problems earlier. Standard tests like HbA1c and fasting glucose offer only a snapshot or an average, and they can miss the spikes and drops that happen throughout the day and after meals. CGMs, by contrast, capture glucose patterns across several days, including the post-meal surges that are often the earliest detectable sign of trouble.23PubMed Central. Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups
CGMs are not yet part of standard screening guidelines, and they are significantly more expensive than a simple blood draw. Their role in diagnosis remains experimental. But for people with borderline test results who want a clearer picture of their daily glucose behavior, or for those whose HbA1c may be unreliable due to conditions like anemia, CGM data can add a useful dimension. The technology is becoming more affordable and accessible, so it may play a larger role in early detection in coming years.
Why People Delay Getting Tested
Knowing that a test exists and actually getting it done are different things. Research into the psychosocial barriers that keep people from seeking diabetes care has identified several recurring themes. Financial constraints and lack of insurance are significant in many countries, but even where cost is not an issue, factors like fear of the diagnosis itself, difficulty navigating healthcare systems, and language barriers for ethnic minorities play a role. Cultural beliefs about illness and trust in physicians also affect whether someone follows through on screening recommendations.24Primary Care Diabetes. Psychosocial barriers to healthcare use among individuals with diabetes mellitus: A systematic review If you have been putting off getting tested, recognizing what is holding you back is a practical first step. A fasting glucose test is inexpensive, widely available, and can be done at a routine doctor’s visit or even at many community health fairs and pharmacies.
The reality is that finding type 2 diabetes early, or catching prediabetes before it progresses, gives you the most options and the best outcomes. Once complications have started, treatment becomes about management and damage control. Before that point, especially at the prediabetes stage, the trajectory can genuinely be changed with measures that do not involve medication at all. The sooner you know where your blood sugar stands, the more leverage you have.